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Abstract
Background
Evaluating tissue heterogeneity using non-invasive imaging could potentially improve pros-
tate cancer assessment and treatment.
Methods
20 patients with intermediate/high-risk prostate cancer underwent diffusion kurtosis imaging,
including calculation of apparent diffusion (Dapp) and kurtosis (Kapp), prior to radical prostatec-
tomy. Whole-mount tissue composition was quantified into: cellularity, luminal space, and
fibromuscular stroma. Peripheral zone tumors were subdivided according to Gleason score.
Results
Peripheral zone tumors had increased cellularity (p<0.0001), decreased fibromuscular
stroma (p<0.05) and decreased luminal space (p<0.0001). Gleason score4+3 tumors
had significantly increased cellularity and decreased fibromuscular stroma compared to
Gleason score3+4 (p<0.05). In tumors, there was a significant positive correlation
between median Kapp and cellularity (ρ = 0.50; p<0.05), and a negative correlation with
fibromuscular stroma (ρ = -0.45; p<0.05). In normal tissue, median Dapp had a significant
positive correlation with luminal space (ρ = 0.65; p<0.05) and a negative correlation with cel-
lularity (ρ = -0.49; p<0.05). Median Kapp and Dapp varied significantly between tumor and
normal tissue (p<0.0001), but only median Kapp was significantly different between Gleason
score4+3 and3+4 (p<0.05).
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Conclusions
Peripheral zone tumors have increased cellular heterogeneity which is reflected in mean
Kapp, while normal prostate has a more homogeneous luminal space and cellularity better
represented by Dapp.
Introduction
Prostate cancer (PCa) is the most common male cancer in the US and Europe and the inci-
dence is increasing [1]. The routine clinical assessment of PCa involves histopathological evalu-
ation following biopsy to determine a Gleason score (GS), which is primarily based on tissue
architecture rather than cytological features [2,3]. This score can predict disease aggressiveness
and treatment failure [4,5]. Unfortunately, accurate pre-treatment assessment of PCa aggres-
siveness remains difficult due to the limitations of biopsy, including sampling error [6,7].
There has been recent interest in combining information from histopathology with imaging, as
well as other tissue-based biomarkers, to allow for better disease assessment [8,9].
Magnetic resonance imaging (MRI) is the main imaging modality for the diagnosis, staging
and determination of treatment response in prostate cancer. Clinical MRI routinely incorpo-
rates diffusion weighted imaging (DWI), which detects the molecular movement of water in
tissue, and how this is altered in the highly cellular tumor environment [10–15]. Quantitative
parameters can be obtained from a series of diffusion-weighted MRI acquisitions at different
diffusion gradient strengths by fitting to a mathematical model used to describe the decay of
measured MRI signal with increasing amounts of applied diffusion weighting or b-value. Diffu-
sional kurtosis imaging (DKI) is an extension of DWI that attempts to further quantify water
diffusion by evaluating non-Gaussian diffusion within each voxel [16]. When applied to DWI,
kurtosis theoretically reflects how the presence of cells and the heterogeneous nature of tissue
structure may distort the normal distribution of water diffusion. DKI derives two quantitative
metrics: the “apparent diffusion coefficient” (Dapp) and a unitless “apparent kurtosis” parame-
ter (Kapp). The role of DKI in PCa has been evaluated previously in retrospective studies, and
the results suggest a possible correlation between Kapp and disease aggressiveness [17–20].
However evaluation of the biophysical basis of DKI and its correlation to the changes in tissue
composition that occur in prostate cancer has been limited. Therefore, the objective of this
study was: to assess the histological tissue composition of normal tissue and tumors of different
grade from the peripheral zone (PZ) of the prostate, and to correlate these variations in compo-
sition with non-invasive imaging of water diffusion pre-prostatectomy using the apparent dif-
fusion (Dapp) and apparent kurtosis (Kapp) parameters derived from DKI.
Materials and Methods
This study was a prospective single-institution trial, approved by the local institutional review
board (IRB) and ethics committee (Cambridgeshire 10/H0304/54). Informed written patient
consent was obtained on a paper consent form. This consent procedure was approved by the
ethics committee.
Consecutive eligible patients were approached and twenty-six patients with PCa were
enrolled between July 2011 and April 2012. Inclusion criteria were: (1) biopsy-proven prostate
cancer considered intermediate/high risk using the D’Amico risk classification system [21]; (2)
radical prostatectomy planned; (3) needle-biopsy performed at least 6 weeks before study MRI
to reduce the effects of hemorrhage. Exclusion criteria were: (1) severe artifact on DWI; (2)
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significant tumor (defined as> 0.5 cm3) present only in the transition zone. 6 patients were
excluded because of substantial susceptibility artifact on DWI (n = 1) or because significant
cancer was not present in the PZ (n = 5). Therefore the final study population constituted 20
patients.
MR imaging
Diffusion-weighted echo-planar imaging was acquired with a 3 Tesla Signa HDx scanner (GE
Healthcare, Waukesha, WI) using an 8-channel phased array coil. Imaging parameters were as
follows: echo/repetition time 89/5000 ms; 8 or more signal averages; field-of-view 32x32 cm2;
matrix 256x256; slice thickness was 4 mm with a gap between slices of 1 mm; parallel imaging
factor of 2; acquisition time of 6 minutes 45 seconds. The use of echo-planar imaging, in con-
junction with parallel imaging, allows for rapid data acquisition significantly reducing artifact
due to motion, blurring, and distortion [22, 23]. The b-value of a DWI or DKI acquisition mea-
sures the degree of diffusion weighting applied. For this study b-values of 150, 600, 1050 and
1500 s/mm2 were used. The b-values were chosen to include a non-zero low b-value (150 s/
mm2), two additional b-values evenly spaced between 150 s/mm2 and 1500 s/mm2 (600, 1050
s/mm2), as well as a high b-values of 1500 s/mm2. A b-value of 0 s/mm2 was not included as
studies have shown that low b-values can be susceptible to pseudoperfusion bias which can be
avoided by using a low b-value>100 [24]. The upper range of the b-values was determined to
allow for successful DKI parameter calculation, while also seeking to minimize the biasing/con-
founding effects of noise on high b-value images. At least 3 separate b-value acquisitions are
required for DKI fitting. Axial T1-weighted (T1W) images and high-resolution T2-weighted
(T2W) images of the pelvis were acquired in axial, sagittal and coronal planes. Noise compensa-
tion was performed through acquisition of a noise-only image by using the identical acquisition
and reconstruction without using the usual radiofrequency excitation pulses. The DKI model
used a second-order approximation to the exponential dependence of DWI signal S with b-
value (b):
S ¼ S0expðbDapp þ 1=6b2Dapp2KappÞ
where S0 is the signal when b = 0 s/mm
2, Dapp is the apparent diffusion coefﬁcient, and Kapp is
the apparent diffusional kurtosis. Quantitative maps of Dapp and Kapp were calculated using
custom software written in Matlab (Mathworks, MA, USA), with the measured signals for each
pixel against b-value ﬁtted to the above equation by non-linear ﬁtting using the trust-region
reﬂective algorithm. For noise compensation, the noise parameter (n) was measured from the
mean of the noise-only images (after smoothing with a 25×25 pixelwise adaptive Wiener ﬁlter)
divided by
ﬃﬃﬃﬃﬃﬃﬃﬃ
2=p
p
and the data was ﬁtted to the expected signal biased by noise (Sn) which is
given by the root mean square of the modeled signal without noise (S) at the measured noise
level, according to the following equation:
Sn ¼ ðS2 þ n2Þ1=2
Histopathology assessment and comparison with imaging
Following surgery, each ex vivo prostate was fixed in formalin and processed according to
international recommendations [25]. The specimen was measured in three dimensions and
was oriented by the location of the seminal vesicles, posterior surface of the prostate, and by
the position of the urethra. The surgical margins were inked. The apical end and basal cone
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were amputated, sliced from left to right into 4 mm thick pieces, and placed in small cassettes pre-
serving their order. The remaining gland was cut transversely into 5 mmwhole-mount parallel
slices in the horizontal plane from inferior to superior. A cutting guide was used to hold the pros-
tate so that there was neither tissue loss nor distortion when slicing into the transverse slices. Pack-
ing material was also added to the cassettes to avoid distortion of the large slices during standard
tissue processing. Five-micron sections were taken from each of the 5 mmwhole-mount parallel
slices for histopathologic analysis. Tumor was outlined on hematoxylin and eosin (H&E) stained
sections from each slice by an experienced uropathologist specializing in PCa (> 10 years of expe-
rience in uropathology). Each slice was manually co-registered to a corresponding MR image,
allowing for the effects of tissue processing if necessary, based on the location of anatomical fea-
tures (prostatic hyperplasia nodules, ejaculatory ducts, urethra), the relative diameter of the pros-
tate, and the approximate distance from the base or apex. Two radiologists (2 and 7 years of
experience with prostate MRI) in consensus determined tumor location onMRI by matching
T2WMRI with the histopathological slides and transferring the outline of the largest PZ tumor on
histology to the Dapp maps. A second equivalent outline was drawn in the contralateral normal PZ.
Image segmentation
The histopathologist reviewed the digitalized whole-mount slides (20x magnification) and digi-
tally outlined regions of prostate cancer and normal prostate tissue to match the previously
established radiologic and pathologic regions of interest. Tumors were categorized into two
categories of aggressiveness according to GS: GS 3+4 and GS 4+3. This distinction effec-
tively subdivides GS 7 disease according to the primary Gleason grade and has been shown pre-
viously to be clinically significant [26,27]. Tissue components within the regions of interest
were identified using color-based segmentation (positive pixel count algorithm v9.0 in Image-
Scope v11.2; Aperio, Vista, CA) similar to the methods of [15]. Initial image segmentation for
each histopathologic slice was completed using a hue setting of 0.7 and a window setting of
0.35. These initial settings resulted in correct color segmentation for a majority of pixels into
the required tissue components. Subsequently a test region for each slice was used to slightly
modify the window and hue settings to minimize the number of pixels identified incorrectly
(median absolute adjustment = 0.04; maximal adjustment = 0.08) due to variations in slice
thickness and staining intensity. A single author determined the settings using visual assess-
ment for each slice to allow for uniformity between slices regarding the correct identification of
pixels as belonging to either the tissue cellularity or fibromuscular stromal matrix (FSM).
These setting were verified for accuracy by the histopathologist who independently processed a
subset (n = 10) of the cases for comparison. After segmentation the positive pixel count algo-
rithm provided the total number of pixels within the region of interest, which were positive, or
corresponding to tissue cellularity. This number was subtracted from the total number of pixels
counted to acquire the total number of pixels within the region of interest, which were negative,
or corresponding to FSM. By using pixel size these figures were converted into area. The com-
bined area of cellularity and FSM was subtracted from the total region of interest area to calcu-
late the luminal space area. The fractional area of cellularity and FSM was calculated as the
ratio of the segmented area for each of the histological descriptors to the total region of interest
(Fig 1). Luminal space corresponded to the difference between the total tissue area and the
summed area of the pixels for cellularity and FSM.
Statistical analysis
Medians and ranges were used to summarize continuous variables. Frequencies and percent-
ages were used to summarize categorical variables. The Wilcoxon Rank Sum test was used to
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assess the relationships between DKI parameters and fractional tissue with disease aggres-
siveness (GS group) or tissue type (normal or PZ tumor). The correlations between fractional
tissue components and median Dapp or median Kapp were evaluated using Spearman’s Rank
correlation. Statistical analyzes were performed using SAS 9.2 software (SAS Institute, Cary,
NC); p-values< 0.05 were considered statistically significant.
Results
Overall, 20 subjects with significant PZ tumors were included (Table 1). The median time
between biopsy and study MRI for the study subjects was 10 weeks (range 6–25 weeks). The
median time between study MRI and prostatectomy was 10.5 days (range 0–34 days). The
number of tumor ROIs (which was the same as matched normal ROIs) per patient depended
Fig 1. Digitalized prostate histopathology. A, B: Histologic prostate tissue sections (x10 objective) from
regions of PZ tumor tissue with a Gleason grade of 3. Each H&E stained whole-mount section was digitalized
at x20 resolution (A). The digitalized slide was then segmented, using a positive pixel counting algorithm, into
three main tissue components (B): cellularity (orange and yellow), fibromuscular stromal matrix (FSM, blue),
and luminal space (white). This Gleason grade 3 region has limited luminal space and is highly cellular; the
malignant glandular architecture is infiltrating into the surrounding FSM. C, D: The H&E stained whole-mount
section from a primarily Gleason grade 4 region (C) was also digitalized at x20 resolution and segmented (D).
This Gleason grade 4 region shows complex architecture with limited luminal space and malignant cellularity,
which has extensively infiltrated and almost completely replaced the FSM.
doi:10.1371/journal.pone.0159652.g001
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on the size of the tumor and varied from 1–4 (mean 2). The tumor ROI size ranged from 3.1–
365.4 mm2 (mean 92.0 mm2).
Fractional tissue composition in PZ tumor and normal tissue
Table 2 displays the fractional tissue composition found in both PZ tumor and normal tissue.
PZ tumors had a significantly greater fractional area of cellularity compared to normal PZ
(p<0.0001). In addition, PZ tumors had a significantly lower fractional area of FSM compared
to normal PZ tissue (p = 0.019) respectively, and a smaller luminal space (p<0.0001). Higher-
grade PZ tumors had a significantly increased fractional area of cellularity compared to lower-
grade tumors (p = 0.041). There was also a significant difference between higher-grade and
lower-grade tumors in the fractional area of FSM (p = 0.011). There was no difference in the
fractional area of luminal space for higher-grade compared to lower-grade tumors (p = 0.909).
DKI parameters in PZ tumor and normal prostate
PZ tumors had a significantly lower Dapp (median = 1.53 x 10
−3 mm2/s, range 1.08–2.14 vs.
2.07, range 1.73–2.58; p<0.0001; Table 3) and a significantly higher Kapp (median = 0.75, range
0.54–1.29 vs. 0.59, range 0.38–0.72; p<0.0001) when compared to normal PZ prostate tissue
(Fig 2). Higher-grade PZ tumors (GS 4+3) had a significantly increased median Kapp com-
pared to lower-grade tumors (GS 3+4) (median = 0.87, range 0.66–1.29 vs. 0.71, range 0.53–
0.88; p = 0.012). In contrast, higher-grade PZ tumors had a non-significant difference in
median Dapp compared to lower-grade tumors (median = 1.42 x 10
−3 mm2/s, range 1.08–2.16
vs. 1.74, range 1.17–2.18; p = 0.200).
Correlation between tissue composition and DKI
Comparison of the DKI parameters with tissue composition revealed a strong relationship with
median Dapp but not Kapp in normal PZ tissue (Table 4). Median Dapp showed a significant pos-
itive correlation with the fractional area of luminal space (ρ = 0.648; p = 0.002) as well as a
Table 1. Patient Characteristics.
Characteristic
Patient age, years 64 (39–72) *
PSA level (ng/mL) 8.2 (2.0–14.6) *
Gleason score †‡
6 (3+3) 3 (15)
7 (3+4) 9 (45)
7 (4+3) 6 (30)
8 or higher 2 (10)
Pathologic tumor stage †
T2a 2 (10)
T2b 1 (5)
T2c 4 (20)
T3a 12 (60)
T3b 1 (5)
* Data are median and range (in parentheses)
† Data are numbers of patients and percentage (in parentheses)
‡ Surgical Gleason score for largest peripheral zone tumor
PSA = prostate speciﬁc antigen
doi:10.1371/journal.pone.0159652.t001
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significant inverse correlation with the fractional area of cellularity (ρ = -0.487; p = 0.029) for
normal prostate tissue. There was no correlation with fractional area of FSM and median Dapp
(p = 0.840). In contrast, the median Kapp of PZ tumors had a significant relationship with tissue
composition, while the relationship with Dapp was limited. Median Kapp showed a significant
positive correlation with fractional area of cellularity in PZ tumors (ρ = 0.50; p = 0.025) as well
as a significant negative correlation with fractional area of FSM (ρ = -0.45; p = 0.049).
Discussion
This prospective study assessed the fractional tissue composition of normal tissue and periph-
eral zone tumor within the prostate by using digitalized histopathology acquired following
prostatectomy. Tumors had significantly increased cellularity, as well as decreased fibromuscu-
lar stromal matrix (FSM) and a decreased luminal space compared to normal tissue. Further-
more, in more aggressive tumors, the cellularity was further increased and the FSM decreased
without a significant change in the luminal space. These measurements of tissue composition
were subsequently correlated with DKI showing a positive correlation between the median
Kapp and cellularity and a negative correlation with FSM in tumours. Median Dapp had a posi-
tive correlation with luminal space and a negative correlation with cellularity in normal tissue.
The differences between the correlation of Kapp with tumor tissue and the correlation of
Dapp with normal tissue could be explained by the biophysical nature of water diffusion. It is
proposed that DWI largely measures water diffusion in the extracellular compartment [28]. A
significant portion of this is present within the luminal space in normal prostate tissue, and
studies that have investigated Dapp and percentage luminal area have found a significant
Table 2. Fractional areas of tissue components for peripheral zone tumors and normal prostate.
Tissue Component Normal Tumor
Cellularity 0.24 (0.10–0.40) 0.39 (0.32–0.61) < 0.0001*
Fibromuscular stromal matrix 0.55 (0.45–0.65) 0.5 (0.32–0.55) 0.0192*
Luminal space 0.2 (0.11–0.33) 0.09 (0.06–0.21) < 0.0001*
GS 3+4 or lower GS 4+3 or higher
Cellularity 0.38 (0.35–0.47) 0.44 (0.32–0.61) 0.0279*
Fibromuscular stromal matrix 0.52 (0.45–0.55) 0.45 (0.32–0.51) 0.0049*
Luminal space 0.09 (0.06–0.15) 0.09 (0.06–0.21) 0.91
Data are median with range in parentheses
*Signiﬁcant difference at p < 0.05
GS = Gleason score
doi:10.1371/journal.pone.0159652.t002
Table 3. DKI quantitative measures for peripheral zone tumors and normal prostate.
DKI measurement Normal Tumor p-value
Dapp (x 10
−3 mm2/s) 2.07 (1.73–2.58) 1.53 (1.08–2.14) < 0.0001*
Kapp (unitless) 0.59 (0.38–0.72) 0.75 (0.53–1.29) < 0.0001*
GS 3+4 or lower GS 4+3 or higher
Dapp (x 10
−3 mm2/s) 1.74 (1.17–2.07) 1.41 (1.08–2.14) 0.20
Kapp (unitless) 0.72 (0.53–0.88) 0.87 (0.66–1.29) 0.0122*
Data are median with range in parentheses
*Signiﬁcant difference at p < 0.05
DKI = diffusional kurtosis imaging; GS = Gleason score
doi:10.1371/journal.pone.0159652.t003
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Fig 2. Image segmentation and DKI in a GS 4+5 right PZ tumor.MR imaging (A-C) and corresponding histopathological sections (D-F) from a 64 year-old
man with Gleason score 4+5 prostate cancer (defined by white region of interest in A-D) and a pre-operative prostate-specific antigen (PSA) level of 6.7 ng/
mL. A: Axial T2W-MRI shows a right peripheral zone tumor visible due to its low signal intensity compared to the surrounding peripheral zone. B: The axial
Dapp map (b-values of 150, 750, 1000, 1500 s/mm
2) shows highly restricted diffusion within the tumor ROI with a median Dapp of 1.08 x 10
−3 mm2/s. C: Axial
Kapp map shows increased diffusional kurtosis in the tumor ROI with a median Kapp of 1.28 (scale bar shown).D:H&E stained slide (x0.2 objective) shows a
region of GS 4+5 tumor, which corresponds to the tumor ROI shown on MRI. E, F: Image segmentation (x0.5 and x10 objectives respectively) shows a highly
aggressive tumor with the following fractional tissue composition: 0.61 cellularity; 0.32 FSM; 0.07 luminal space.
doi:10.1371/journal.pone.0159652.g002
Table 4. Correlation between the fractional areas of each tissue component and the two quantitative DKI parameters.
Dapp Kapp
Rho p-value Rho p-value
Normal prostate
Cellularity -0.487 0.029 -0.081 0.73
Fibromuscular stromal matrix -0.049 0.84 0.336 0.15
Luminal space 0.648 0.002 -0.233 0.32
Peripheral zone tumor
Cellularity -0.415 0.07 0.499 0.025
Fibromuscular stromal matrix 0.199 0.40 -0.445 0.049
Luminal space 0.228 0.33 -0.128 0.59
doi:10.1371/journal.pone.0159652.t004
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positive correlation between these two parameters [15,29]. In contrast to luminal space, which
largely represents an area with free water diffusion, the FSM and cellular regions of tissue have
increased tissue complexity creating barriers to the free diffusion of water [28]. The results pre-
sented here support the hypothesis that DKI is probing the heterogeneity of tumor tissue,
which contrasts with the more homogeneous normal tissue. This is further supported by a pre-
vious study that found a restrictive effect of cellularity and FSM on the diffusion of water in
prostate tissue using high field microimaging of ex vivo prostate samples [30].
In this study, the positive correlation between median Kapp and tumor cellularity, in association
with the negative correlation with FSM, provides a possible biological basis for the significant dif-
ference in median Kapp detected between lower-grade and higher-grade PZ tumors. A retrospec-
tive study by Rosenkrantz et al. found that Kapp was significantly increased in the biopsied prostate
regions with GS 7 or 8 tumor, compared to those with GS 6 [17]. A significant difference for DKI
parameters obtained from tumors with GS 6 compared to GS 7 or higher has been shown by other
retrospective studies [18–20, 31]. This ability to accurately differentiate GS 6 disease could be use-
ful in the setting of active surveillance. The prospective study presented here expands upon this
work correlating DKI with aggressiveness and, importantly, compares the results with the tissue
composition derived following prostatectomy. Instead of using a cut-off of GS 7 or higher, as has
been undertaken in other studies, this study subdivided GS 7 disease to further investigate the
underlying biological basis for the change in diffusion parameters. The increase in tissue heteroge-
neity that occurs as the tumor shifts from Gleason grade 3 to 4 could explain why a significant dif-
ference in Kapp was detected between lower-grade and higher-grade disease in this study. Studies
have previously shown the clinical significance of GS 3+4 versus GS 4+3 [26,27] and the Interna-
tional Society of Urological Pathology recently proposed a new grading system, which more clearly
makes this distinction [32]. This study provides evidence that Kapp offers a potential measure of
tissue heterogeneity and cellularity, which could be used to discriminate higher-grade from lower-
grade tumors, and further research investigating its possible role is warranted.
This study has also demonstrated that both the apparent diffusion (Dapp) and apparent kur-
tosis (Kapp) showed a statistically significant difference between PZ prostate cancer and
matched normal prostate. Previous studies that have investigated the ability of DKI to detect
PCa lesions have found mixed results. In a retrospective study of 47 patients using biopsy
results as a reference standard, Rosenkrantz et al. [17], found that Kapp showed a greater sensi-
tivity (93.3%) for differentiating cancerous sextants from benign PZ compared to either ADC
(78.5%) or Dapp (83.5%) however this was associated with a decreased specificity for Kapp
(70.0%) compared to ADC or Dapp (81.4% and 82.9% respectively). In addition two other
smaller studies did not demonstrate a clear improvement in tumor detection using DKI [33,
34]. The results of this study suggest that the principal benefit for DKI, Kapp in particular, is
regarding its association with tumor aggressiveness and highlighting regions or tumors with
more aggressive tissue characteristics.
Assessing tumor aggressiveness by combining measurements from both histopathology and
non-invasive imaging is important for accurate disease characterization and treatment [8,9].
Furthermore, non-invasive imaging can be used to more accurately guide tissue sampling of
the prostate, and thus further improve the characterization of the tumor [35]. The results from
this preliminary study show that DKI could aid in the direct sampling of regions with increased
aggressiveness or tissue heterogeneity, and therefore could assist in the histopathological
assessment of the disease in the future.
Our study has some limitations. First, this was a preliminary study with a small sample size
and we were limited to univariate analysis; despite this, clear statistically significant results
were demonstrated and future evaluation in a larger patient group is required. Second, our
study was limited to PZ tumors because there were few TZ tumors in this cohort. Third,
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accurate correlation between imaging and histopathology is methodologically challenging:
while every effort was made to correlate histopathology and imaging, some mis-registration
may have occurred. Fourth, this study did not specifically evaluate the presence of neovascular-
ization either through the DKI parameters or the tissue composition work. Such evaluation
could be useful in further studies. Finally, the Gleason score was used as a surrogate of clinical
outcome as a well established predictor of clinical outcome after radical prostatectomy and
radiation therapy; longitudinal studies are required to directly correlate these imaging findings
with clinical outcome over many years.
Conclusions
In summary, this study builds on previous work in the field of diffusion-weighted imaging of the
prostate and, in the setting of a prospective study, relates DKI to tissue structure using histopa-
thology acquired from prostatectomy. By comparing DWI parameter maps with histological sec-
tions, this work has demonstrated the structural changes in tissue composition that occur in
normal prostate tissue and in tumor, and between tumors of different grade. Using this method-
ology, this study has provided an explanation of the biological basis for the metrics derived from
DKI. The two parameters obtained—Dapp and Kapp—provide complementary information: Dapp
probes the relatively homogeneous luminal space and cellularity present in normal prostate and
was significantly lower in PZ tumor compared to normal prostate; Kapp reflects the increase in
cellular heterogeneity present in PZ tumors and was significantly higher in more aggressive
tumors compared to less aggressive ones. This distinction in GS is important clinically: accurate
non-invasive evaluation of the tissue structure and tumor grade within a suspected prostate can-
cer could help to determine which men may require a biopsy, and could help to stratify patients
into those suitable for active surveillance and those who should receive focal therapy or surgery.
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